Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Page 13 Page 14 Page 15 Page 16 Page 17 Page 18 Page 19 Page 20 Page 21 Page 22 Page 23 Page 24 Page 25 Page 26 Page 27 Page 28 Page 29 Page 30 Page 31 Page 3213 in China, which provides critical compliance guidance for medtech companies doing business in China, and developed numerous tools and awareness materials to assist members with China Code implementation. •  AdvaMed launched a compliance app for mobile devices (via iTunes) with features to assist industry interactions and discussions with health care providers on issues under the AdvaMed Code and Sunshine Act. PHYSICIAN-OWNED DISTRIBUTORS (PODS) AdvaMed reconstituted its working group on PODs in 2015 and submitted written testimony to the Senate Finance Committee outlining long-standing industry concerns with the entities, which HHS’s Office of Inspector General determined “produce substan- tial fraud and abuse risk and pose dangers to patient safety.” ­ The Association also advocated against hospital purchasing policies targeting PODs that unfairly discriminate against physician-owned small companies. DEVICE TAX In late 2015, AdvaMed advocacy led to a two-year suspension of the innovation-crushing medical device excise tax. To address issues surrounding implementation of the suspension, AdvaMed reconvened its Device Tax Working Group to consider the short- term legal effects, with plans to coordinate as necessary with the IRS and other stakeholders on interim guidance. The Honorable David Pearce, U.S. ambassador to Greece (at left), addresses attendees of AdvaMed’s Global MedTech Compliance Conference in Athens, including Michael Mussallem, chairman and CEO of Edwards Lifesciences, and Jeffrey Dunn, president and CEO of SI-Bone (at right). Leo Tsao, assistant chief of the fraud section of the U.S. Department of Justice, Criminal Division (at right), Colleen Conry, partner at Ropes & Gray, and Adam Morris, senior legal counsel, global investigations, at Medtronic (at left), discuss anti-corruption trends in emerging markets at AdvaMed 2015.